The Americas

  • Business roundup: AI platform to accelerate medical research and more

    Health Tech World explores the latest business and pharmaceutical developments in the world of health technology. AI platform to accelerate medical and epidemiological research Health technology company Briya has announced the launch of Briya AIRE, the world's first clinical-grade AI research assistant built to accelerate biomedical and clinical decision making. Designed to "think" in the [...]

  • McDermott advises Oaktree On $125m term loan facility to Oxford Biomedica

    McDermott Will & Schulte advised funds managed by Oaktree Capital Management, L.P. (“Oaktree”) in connection with a new four-year term loan facility of up to $125 million provided to OXB (LSE: OXB), a leading cell and gene therapy contract development and manufacturing organization (CDMO). The facility includes $60 million in initial funding, the majority of [...]

  • Interview: Transforming genetic testing for rare diseases with AI

    Software company 3Billion is innovating genetic testing for rare diseases with AI. Health Tech World speaks to CEO Changwon Keum to find out more. Founded in 2016 as exome and whole genome-based genetic testing services were emerging, 3Billion is harnessing AI to innovate genome interpretation. The company's AI-powered genetic testing diagnoses rare diseases more accurately [...]

  • Off-the-shelf cancer vaccine could lower risk of relapse, study suggests

    An off-the-shelf cancer vaccine has shown potential in lowering the risk of pancreatic and colorectal cancer returning after surgery. The jab works by training the immune system to target and destroy cancer cells that may return after treatment, aiming to reduce relapse. Unlike personalised mRNA vaccines tailored to individual tumours, this non-personalised vaccine is already [...]

  • RFK health dept to terminate 22 mRNA vaccine research contracts

    The US Department of Health and Human Services said it would terminate 22 contracts for mRNA vaccine projects, questioning the safety of the technology. The cancelled contracts, worth nearly US$500m, include one with Moderna for development of a bird flu vaccine and rejected proposals from Pfizer, Sanofi Pasteur, CSL Seqirus and Gritstone. The Biomedical Advanced [...]

  • Imprivata introduces new face authentication tech

    Imprivata has introduced advanced face authentication technology to further expand the company’s passwordless capabilities. The cutting-edge solution is optimised for both shared and personal devices, providing frontline workers with secure, seamless, and consistent authentication across their endpoints, applications, and workflows. This allows organisations to eliminate password friction and drive productivity while maintaining strong identity assurance [...]

  • Aidoc raises US$150m for clinical AI expansion

    Aidoc has raised US$150m to expand CARE, its clinical AI platform that helps doctors make faster, more accurate medical decisions at the point of care. The funding round was led by General Catalyst and Square Peg, with support from NVentures (NVIDIA’s venture capital arm) and four major US health systems: Hartford HealthCare, Mercy, Sutter Health [...]

  • Neuralink targets 20,000 brain chip patients by 2031

    Elon Musk’s Neuralink expects to implant brain chips in 20,000 people annually by 2031, generating at least US$1bn a year, according to documents reviewed by Bloomberg. The company plans to operate around five large clinics within six years and offer at least three versions of its device, according to a recent presentation shown to investors. [...]

  • Roundup: Partnership to revolutionise treatment of liver tumours, and more

    Health Tech World explores the latest business developments in the world of health technology. Partnership to revolutionise treatment of liver tumours Proximie - a health technology platform digitising operating rooms - has announced a partnership with HistoSonics, the manufacturer of the Edison Histotripsy System1 and novel histotripsy therapy platforms used for non-invasive treatment of liver [...]

  • Chief AI officer: A role the NHS doesn’t need?

    By Paul Wye, Head of AI, Answer Digital The topic of whether healthcare providers should appoint Chief AI Officers (CAIOs) is no longer theoretical. The United States has been embedding these roles within healthcare systems for a number of years, and just recently a trailblazing consultant has been named as Scotland’s first Head of AI [...]